2019 annual financial data
Aligos Therapeutics, Inc. 2019 Operating margin
Aligos Therapeutics, Inc. 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -54,043,000 USD and net income was -52,264,000 USD.
Operating cash flow was -46,767,000 USD.
Get free Aligos Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -54,043,000 USD
- Net income
- -52,264,000 USD
- Operating cash flow
- -46,767,000 USD